NYSE American - Delayed Quote USD

NovaBay Pharmaceuticals, Inc. (NBY)

0.0773 +0.0003 (+0.39%)
At close: April 24 at 4:00 PM EDT
0.0747 -0.00 (-3.36%)
After hours: April 24 at 7:49 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Justin M. Hall Esq. President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director 364.15k -- 1978
Mr. Tommy Law Controller, Interim CFO & Treasurer 177.7k -- 1985

NovaBay Pharmaceuticals, Inc.

2000 Powell Street
Suite 1150, eleventh floor
EmeryVille, CA 94608
United States
510 899 8800 https://novabay.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
24

Description

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Corporate Governance

NovaBay Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 09, 2024 - May 13, 2024
NovaBay Pharmaceuticals, Inc. Earnings Call

Related Tickers

GRTX Galera Therapeutics, Inc.
0.1827
-5.82%
 
ASLN ASLAN Pharmaceuticals Limited
0.4700
+1.08%
 
ELAB Elevai Labs, Inc.
0.6040
+1.51%
 
CLNN Clene Inc.
0.3370
+0.57%
 
ABVC ABVC BioPharma, Inc.
1.4800
+9.63%
 
KTRA Kintara Therapeutics, Inc.
0.1373
+3.47%
 
ALLR Allarity Therapeutics, Inc.
1.3700
-3.52%
 
NKGN NKGen Biotech, Inc.
1.7100
-7.57%
 
EYEN Eyenovia, Inc.
0.5835
+7.54%
 
PHIO Phio Pharmaceuticals Corp.
0.6710
-4.25%